Comprehensive coverage on the latest pharmaceutical regulatory update and industry activities in China.
Law & Regulation Pharmacopoeia MAH Pharmacovigilance Marketing Approval Innovative Drug Drug Registration New DrugCRAC-HCF 2021 | Embracing China's Pharma Market With Regulatory Compliance and Industry Insights Five experts from drug regulation authorities, pharmaceutical companies, and consulting firms decoded drug regulations and analyzed industry dynamics for international pharma companies to develop businesses in the Chinese market.
Nov 17, 2021
Law & Regulation Pharmacopoeia MAH Pharmacovigilance Marketing Approval Innovative Drug Drug Registration New DrugOnline Conference | China Drug Regulation and Pharmaceutical Market BaiPharm will hold a virtual conference on Nov. 12, as part of the CRAC-HCF 2021 event. We will have five speeches elaborating on China drug regulations and pharmaceutical market. The specific topics include China market entry strategy, Chinese Pharmacopoeia, GVP, MAH, and innovative drug research.
Oct 21, 2021
- 2021 China CDE Drug Evaluation Report
- Monthly Report: New Drug Approvals in China | June 2022
- China Kicks off the 7th Round of Volume-based Procurement (VBP) of Drugs
- China Emphasizes Rare Disease & Pediatric Drugs in Adjusting the 2022 National Reimbursement Drug List (NRDL)
- Licensing Deals Involving Chinese Pharma Companies in H1 2022